Stock Quote Search
Latest News
- The Facebook Sell-Off: Will Shares Recover?
- Gasoline Prices Keep Falling But Relief Could Be Short Lived
- Yahoo! Makeover Continues With Alibaba Deal
- Fed More Bullish Than Wall Street Forecasting Growth
- Ex-Goldman Director Rajat Gupta Faces U.S. Jury in Insider Case
- Hope for More Bailouts Boosts Global Stocks, But Can’t Save Facebook
- Poverty Increasing Among Retirees
- Court Won't Reduce Student's $675,000 Music Download Fine
- New York Penthouse Sets Record $90 Million Sale
- Student Loan Bubble Putting Hundreds of Colleges at Risk
Site Search
CVS Caremark, ConAgra, Netflix are big movers
Created on Tuesday, 20 December 2011 14:37Category: Financial News Highlights
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and Nasdaq Stock Market:
NYSE
ConAgra Foods Inc., up $1.02 at $26.19
The food maker reported that its second quarter net income fell 15 percent, but results beat expectations as it raised prices.
General Mills Inc.,
The maker of Cheerios, Nature Valley granola and Hamburger Helper said its net income fell 28 percent during the second quarter.
CVS Caremark Corp., up $3.24 at $39.80
The drugstore chain raised its quarterly dividend 30 percent and said it expects 2012 profits at its Caremark unit to grow.
Red Hat Inc., down $4.10 at $41.95
The software company's third-quarter net income rose, but its fourth-quarter revenue forecast fell short of analyst expectations.
Talbots Inc., up 5 cents at $2.69
The women's clothing chain rejected a $205 million buyout offer from its biggest shareholder, private equity firm Sycamore Partners.
Nasdaq
A123 Systems Inc., up 6 cents at $1.59
The maker of rechargeable lithium ion batteries for electric cars said it will supply a battery system to utility Maui Electric Co.
Netflix Inc., up $4.25 at $71.40
In a new deal with BBC Worldwide, the Internet streaming company's U.K. and Irish users will be able to stream the network's shows.
Salix Pharmaceuticals Ltd., up $3.71 at $46.94
The drugmaker and partner Progenics said a study for an expanded use of constipation treatment Relistor yielded positive results.
Courtesy Yahoo News